Get the Stockscreener App
2.255
2.04%
0.045
InspireMD Inc. stock is traded at $2.255, with a volume of 4,841.
It is up +2.04% in the last 24 hours and down -5.65% over the past month.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See More
Previous Close:
$2.21
Open:
$2.18
24h Volume:
4,841
Relative Volume:
0.05
Market Cap:
$95.33M
Revenue:
$6.21M
Net Income/Loss:
$-19.92M
P/E Ratio:
-2.1476
EPS:
-1.05
Net Cash Flow:
$-16.76M
1W Performance:
-0.22%
1M Performance:
-5.65%
6M Performance:
-16.48%
1Y Performance:
-9.07%
1-Day Range:
$2.18
$2.30
1-Week Range:
$2.095
$2.41
52-Week Range:
$1.99
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Name
InspireMD Inc.
Sector
Industry
Phone
972 3 6917691
Address
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.285 | 92.20M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
122.78 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.63 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
357.15 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.22 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
80.85 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-16 | Initiated | Rodman & Renshaw | Buy |
| Mar-13-15 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-26-13 | Initiated | Oppenheimer | Outperform |
InspireMD Inc. Stock (NSPR) Latest News
InspireMD appoints Dr. Peter Soukas as chief medical officer - Investing.com
InspireMD Appoints Dr. Peter A. Soukas as Chief Medical Officer to Advance Carotid Intervention Initiatives - Quiver Quantitative
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer - The Manila Times
InspireMD (NASDAQ: NSPR) names Dr. Peter Soukas CMO as CGuard Prime launches in U.S. - Stock Titan
Why analysts remain bullish on InspireMD Inc. stockCEO Change & Consistent Profit Trade Alerts - newser.com
How InspireMD Inc. stock reacts to Fed rate cuts2025 Big Picture & Scalable Portfolio Growth Methods - newser.com
Can InspireMD Inc. stock weather global recessionMarket Activity Report & AI Driven Stock Reports - newser.com
How risky is InspireMD Inc. (II2) stock compared to peersWeekly Stock Recap & High Accuracy Buy Signal Tips - newser.com
Short interest data insights for InspireMD Inc.Trade Entry Report & Weekly Setup with ROI Potential - newser.com
Can InspireMD Inc. (II2) stock attract ESG investmentsTrade Exit Summary & Proven Capital Preservation Tips - newser.com
Using data filters to optimize entry into InspireMD Inc.July 2025 Fed Impact & Weekly Setup with ROI Potential - newser.com
Backtesting results for InspireMD Inc. trading strategiesQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
What margin trends mean for InspireMD Inc. stockWeekly Stock Report & Community Consensus Stock Picks - newser.com
How InspireMD Inc. (II2) stock responds to job market shiftsEarnings Miss & Technical Entry and Exit Alerts - newser.com
Why InspireMD Inc. (II2) stock remains top rated2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com
How strong dollar benefits InspireMD Inc. (II2) stockJuly 2025 Catalysts & Reliable Momentum Entry Alerts - newser.com
Is InspireMD Inc. stock poised for growthMarket Sentiment Summary & Reliable Price Action Trade Plans - newser.com
How InspireMD Inc. (II2) stock reacts to stronger dollar2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
InspireMD Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Pleasing Signs As A Number Of Insiders Buy InspireMD Stock - Yahoo Finance
Is InspireMD Inc. stock a defensive play in 2025July 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
What to do if you’re stuck in InspireMD Inc.2025 EndofYear Setup & Community Consensus Stock Picks - newser.com
Can InspireMD Inc. stock resist market sell offsJuly 2025 Decliners & Target Return Focused Picks - newser.com
InspireMD Inc. Stock (NSPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):